Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
| العنوان: | Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis |
|---|---|
| المؤلفون: | JP Bae, Darell Heiselman, Anthony Zagar, Eric S. Meadows, Krishnan Ramaswamy, Tomoko Sugihara, Rebecca McCracken |
| المصدر: | BMC Research Notes BMC Research Notes, Vol 5, Iss 1, p 342 (2012) |
| بيانات النشر: | BioMed Central, 2012. |
| سنة النشر: | 2012 |
| مصطلحات موضوعية: | Male, medicine.medical_specialty, Acute coronary syndrome, Ticlopidine, medicine.medical_treatment, lcsh:Medicine, Revascularization, Patient Readmission, General Biochemistry, Genetics and Molecular Biology, Percutaneous Coronary Intervention, Internal medicine, medicine, Myocardial Revascularization, Humans, Acute Coronary Syndrome, Hospital Costs, lcsh:Science (General), Stroke, lcsh:QH301-705.5, Aged, Retrospective Studies, Medicine(all), business.industry, Biochemistry, Genetics and Molecular Biology(all), lcsh:R, Managed Care Programs, Percutaneous coronary intervention, Diagnosis-related group, Drug-Eluting Stents, General Medicine, Length of Stay, Middle Aged, medicine.disease, Clopidogrel, United States, lcsh:Biology (General), Conventional PCI, Emergency medicine, Cardiology, Managed care, Female, business, Platelet Aggregation Inhibitors, medicine.drug, lcsh:Q1-390, Research Article |
| الوصف: | Background While prior research has provided important information about readmission rates following percutaneous coronary intervention, reports regarding charges and length of stay for readmission beyond 30 days post-discharge for patients in a large cohort are limited. The objective of this study was to characterize the rehospitalization of patients with acute coronary syndrome receiving percutaneous coronary intervention in a U.S. health benefit plan. Methods This study retrospectively analyzed administrative claims data from a large US managed care plan at index hospitalization, 30-days, and 31-days to 15-months rehospitalization. A valid Diagnosis Related Group code (version 24) associated with a PCI claim (codes 00.66, 36.0X, 929.73, 929.75, 929.78–929.82, 929.84, 929.95/6, and G0290/1) was required to be included in the study. Patients were also required to have an ACS diagnosis on the day of admission or within 30 days prior to the index PCI. ACS diagnoses were classified by the International Statistical Classification of Disease 9 (ICD-9-CM) codes 410.xx or 411.11. Patients with a history of transient ischemic attack or stroke were excluded from the study because of the focus only on ACS-PCI patients. A clopidogrel prescription claim was required within 60 days after hospitalization. Results Of the 6,687 ACS-PCI patients included in the study, 5,174 (77.4%) were male, 5,587 (83.6%) were Conclusions For ACS patients who underwent PCI, revascularization procedures represented a large portion of rehospitalizations. Revascularization procedures appear to be the most frequent, most costly, and earliest cause for rehospitalization after ACS-PCI. |
| اللغة: | English |
| تدمد: | 1756-0500 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfd72218bee0ae5d6980f8ac092a260eTest http://europepmc.org/articles/PMC3493265Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....dfd72218bee0ae5d6980f8ac092a260e |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 17560500 |
|---|